Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties

Activity: Talk or presentationOral presentation


The cost-effectiveness of diagnosis raises challenges in identifying the possible ways to combine tests, obtaining the pay-offs in terms of long-term outcomes and costs, and understanding uncertainty. We report our approach to these issues in the context of the cost-effectiveness of diagnosis of clinically significant prostate cancer.
The cost-effectiveness analysis took 3 stages. First, we conceptualise and implement the diagnosis model to evaluate the different ways the tests can be used to diagnose a lesion as clinically significant cancer. Second, we obtain the long-term outcomes and costs from correct and incorrect diagnosis and subsequent management. Third, we evaluate and represent the uncertainty in the cost-effectiveness results.
In this seminar, I will walk you through the cost-effectiveness analysis conducted for the PROMIS project, how we approached each of the stages, and insights for future research.
Period17 May 2018
Held atCentre for Health Economics
Degree of RecognitionNational